Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Gynecologic Cancers
•
Gastrointestinal Cancers
How do you manage urgency and frequency of bowel movements secondary to radiation proctitis?
Answer from: Radiation Oncologist at Community Practice
In the acute setting we try anusol HC suppository to decrease tenesmus like symptoms
Comments
Radiation Oncologist at Fox Chase Cancer Center
I agree. There’s not a lot of data here, but we ...
609
Sign in or Register to read more
3402
Related Questions
What are magic mouthwash alternatives that you would recommend?
How do you counsel patients and partners of patients with HPV+ cancers regarding the HPV vaccine?
What are best practices for oncologists during the national platinum shortage?
For patients with peritoneal carcinomatosis and minimal response to neoadjuvant chemotherapy, is there a benefit to palliative cytoreductive surgery followed by whole abdominal radiotherapy?
In patient s/p definitive chemoRT for vulvar cancer with complete response, how do you manage a non-healing vulvar defect if biopsy is negative for residual disease?
Is there a benefit in proactively referring patients treated with pelvic radiation to see pelvic rehabilitation in the absence of any symptoms?
Would re-excision of close margins (1 mm) allow a patient to avoid post-op radiation for a patient with metachronous diagnosis of a FIGO Stage IB vulvar cancer who also had a prior contralateral vulvar cancer resected 15 years ago?
Is there a role for chemotherapy and/or vaginal cuff boost to EBRT in FIGO IB1 cervical adenocarcinoma, status post total hysterectomy?
What is your treatment approach for an adenoma malignum of the cervix?
What intracavitary brachytherapy dose (and fractionation) would you recommend for stage I vaginal cancer post-resection with positive (R1) margins?
I agree. There’s not a lot of data here, but we ...